Concepedia

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients

Young Hwan Park, J. J. Lee, Min‐Hee Ryu, S. Y. Kim, D. H. Kim, K. H. Lee, Seungbae Oh, Y. K. Kim, Cheolwon Suh, Dae Seog Heo,

Annals of Hematology · 2006 · 19 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

, , +17

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 1.9K citations · Full text

, , +14

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

Pierre Feugier, Ambro van Hoof, Catherine Sebban et al. · Journal of Clinical Oncology · 2005 · 1.5K citations

, , +13

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Laurie H. Sehn, Jane Donaldson, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2005 · 989 citations · Full text

, , +8

Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies

Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press · Blood · 1998 · 571 citations · Full text

, , +14